BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
IGF1
,
T cell receptor signaling pathway
,
Leukemia
,
Lung
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
minimal change disease
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
REG1A
FGB
CAPN3
LTF
SERPINA3
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP
RODWELL_AGING_KIDNEY_UP
MODULE_5
HOSHIDA_LIVER_CANCER_SUBCLASS_S3
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Glomeruli from patients with focal segmental glomerulosclerosis or minimal change disease
Tubulointerstitium from kidney disease biopsies
Glomeruli from kidney disease biopsies
Mouse Phenotypes - Kidney diseases
Explore Curated Studies Results
Literature
Most Relevant Literature
Telitacicept for minimal change disease.
A spectrum of novel anti-vascular endothelial cells autoantibodies in idiopathic nephrotic syndrome …
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in…
Clinical value of serum cholinesterase levels in Nephrotic syndrome: an observational study.
Minimal Change Disease in an Adult: A Case Report.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease
Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease
The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registr…
Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minim…
Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Cha…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ